Clinical Trials Logo

Clinical Trial Summary

It was recently shown that neostigmine reversal was associated with increased atelectasis and that high-dose neostigmine was associated with longer postoperative length of stay and with an increased incidence of pulmonary edema and reintubation. These study results were consistent with findings from a previous epidemiological study which revealed an absence of beneficial effects of neostigmine on postoperative oxygenation and reintubation. In our previous study, the effects of neostigmine / glycopyrrolate and sugammadex on the electromyographic activity of the diaphragm showed beneficial effects for sugammadex. This could be explained by a possible effect on neuromuscular transmission at the muscle level, but can also be explained by a neostigmine-induced decrease in total nerve activity. In a study in cats, neostigmine has been shown to reduce efferent phrenic nerve activity. The investigators aim to show a difference in phrenic nerve activity between neostigmine and sugammadex, administered alone or in combination, in healthy male volunteers.


Clinical Trial Description

An auxiliary surface EMG will be recorded via ordinary skin electrodes at the diaphragm, and intercostal and rectus abdominis muscles. The degree of neuromuscular blockade is continuously measured by accelerometry of the adductor pollicis muscle with ulnar nerve stimulation (TOF-watch SX®). Anesthesia is induced with propofol and remifentanil. Manually assisted ventilation with an air/oxygen mixture of 40% oxygen is started as soon as patients are becoming apnoeic. Train-of-four (TOF) monitoring starts after the induction of anesthesia (before rocuronium administration) and continues until awakening. The investigators will insert a 16 Fr. nasogastric catheter which allows electrical activity of the diaphragm (Edi) registration (NAVA, Maquet, Solna, Sweden). After baseline measurements, 0.6 mg/kg rocuronium is injected. After tracheal intubation, subjects will be ventilated by a standard ventilation mode (tidal volume 7 ml/kg, frequency of 12 breaths per minute, inspired oxygen fraction of 30%), with end-tidal PCO2 targets of 30-35 mmHg and a PEEP of 5 cmH2O. SpO2 values will be maintained at ≥98%. Spontaneous recovery is allowed to progress until the re-appearance of the second twitch of the TOF. The volunteers will then receive either sugammadex 2mg/kg or neostigmine 50µg/kg + glycopyrrolate 10µg/kg (using the commercially available 5:1 co-formulation) or neostigmine 50µg/kg followed 3 minutes later by administration of sugammadex 2mg/kg. At the onset of spontaneous respiration, an arterial blood gas sample will be drawn. NAVA catheter positioning will be confirmed using the 'Edi catheter positioning' tool as soon as a signal is received. A second arterial blood gas sample will be drawn at the moment of awakening.

Diaphragm electromyographic activity (Edi, obtained from the NAVA catheter), airway pressure and flow are acquired at 100 Hz from the ventilator via an interface connected to a computer using commercially available software (Maquet Critical Care, Solna, Sweden). The auxiliary surface EMG will be recorded with a dedicated device (Dipha16, InBiolab, Groningen, The Netherlands) at the diaphragm, and intercostal and rectus abdominis muscles. All data will be stored and later analysed. ;


Study Design

Allocation: Randomized, Endpoint Classification: Safety Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Caregiver, Investigator, Outcomes Assessor), Primary Purpose: Basic Science


Related Conditions & MeSH terms


NCT number NCT02403063
Study type Interventional
Source Onze Lieve Vrouw Hospital
Contact
Status Completed
Phase Phase 4
Start date September 2015
Completion date November 2015

See also
  Status Clinical Trial Phase
Not yet recruiting NCT05547477 - Continuous EMG Measurements in Children With Asthma During Sleep
Completed NCT05114629 - Biomechanics of Adaptive Rowing in Active and Inactive Manual Wheelchair Users
Recruiting NCT04538807 - EMG Finding According to the Type of Lumbar Disc Herniation
Completed NCT03715777 - Electromyographic Study for the Help and Guidance of BoNTA Administration in the Treatment of Chronic Pelvic Floor Pain Phase 3
Recruiting NCT05608850 - Acute Responses of Postural Alignment, Kinematic Synergy, and Intermuscular Coherence to Postural Muscle Facilitation N/A
Not yet recruiting NCT03837886 - Effects of Sodium Bicarbonate Supplementation on Intermittent and Intense Task N/A
Recruiting NCT05581680 - Multimodal Quantified Analysis of Facial Movements: Comparison Between Pathological and Control Subjects N/A
Completed NCT03734133 - Electromyography Evaluation of the Impacts of Different Insoles in the Activity Patterns of the Lower Limb Muscles N/A
Not yet recruiting NCT05111652 - Electromyographic Assessment of the Shoulder Stabilizing Musculature in CrossFit® Athletes
Completed NCT02974465 - Electromyographic Biofeedback and Physical Therapy in Upper Limb Hemiparesis N/A
Recruiting NCT04312529 - Analysis of Shoulder Muscle Activity During Isokinetic Evaluation of Rotators N/A
Completed NCT04472247 - Sedation Monitoring Using Frontal Electroencephalogram, Electromyogram and Hemodynamic Responses to Pain in Critical Care
Completed NCT02630576 - Neurostimulation and Electromyographs Assessment of th TetraGraph in Healthy (Volunteers N/A
Recruiting NCT03963258 - Short-Term Effects of Whole-Body Vibration on Upper Extremity Function in Subjects With Poststroke Hemiplegia N/A
Completed NCT06219876 - Comparison of the Efficacy of High Intensity Laser Therapy and Low Level Laser Therapy in the Carpal Tunnel Syndrome N/A
Recruiting NCT05965804 - Vastus Medialis Activation During McMurray's Test
Completed NCT02974452 - Age-related Changes of Shoulder Muscles N/A
Active, not recruiting NCT05281900 - Investigation of Muscular Activation Levels Around the Scapula and Shoulder in Exercises Which Body Weight is Carried N/A
Recruiting NCT04775030 - Methodology for Developing an Occlusal Appliance With CBD Active Carrier Phase 2/Phase 3
Completed NCT03994640 - Myorelaxant Effect of Cannabis Cream Topical Skin Application in Patients With TMD Phase 2/Phase 3